57 related articles for article (PubMed ID: 38459596)
1. Exosomal circPOLQ promotes macrophage M2 polarization via activating IL-10/STAT3 axis in a colorectal cancer model.
Sun Z; Xu Y; Shao B; Dang P; Hu S; Sun H; Chen C; Wang C; Liu J; Liu Y; Hu J
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38782541
[TBL] [Abstract][Full Text] [Related]
2. Exosome-mediated communication between gastric cancer cells and macrophages: implications for tumor microenvironment.
Qiu Y; Lu G; Li N; Hu Y; Tan H; Jiang C
Front Immunol; 2024; 15():1327281. PubMed ID: 38455041
[TBL] [Abstract][Full Text] [Related]
3. Mysterious interactions between macrophage-derived exosomes and tumors; what do we know?
Saleh RO; Hjazi A; Bansal P; Ahmad I; Kaur H; Ali SHJ; Deorari M; Abosaoda MK; Hamzah HF; Mohammed BA
Pathol Res Pract; 2024 Apr; 256():155261. PubMed ID: 38518733
[TBL] [Abstract][Full Text] [Related]
4. Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p/STAT6 axis to promote gastric cancer progression.
Deng C; Huo M; Chu H; Zhuang X; Deng G; Li W; Wei H; Zeng L; He Y; Liu H; Li J; Zhang C; Chen H
Mol Cancer; 2024 Mar; 23(1):49. PubMed ID: 38459596
[TBL] [Abstract][Full Text] [Related]
5. Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p.
Cai J; Qiao B; Gao N; Lin N; He W
Am J Physiol Cell Physiol; 2019 May; 316(5):C731-C740. PubMed ID: 30811223
[TBL] [Abstract][Full Text] [Related]
6. Gastric cancer-derived exosomal miR-519a-3p promotes liver metastasis by inducing intrahepatic M2-like macrophage-mediated angiogenesis.
Qiu S; Xie L; Lu C; Gu C; Xia Y; Lv J; Xuan Z; Fang L; Yang J; Zhang L; Li Z; Wang W; Xu H; Li B; Xu Z
J Exp Clin Cancer Res; 2022 Oct; 41(1):296. PubMed ID: 36217165
[TBL] [Abstract][Full Text] [Related]
7. Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p/HUR/VEGF axis and suppressing HSP90 degradation.
Xie M; Yu T; Jing X; Ma L; Fan Y; Yang F; Ma P; Jiang H; Wu X; Shu Y; Xu T
Mol Cancer; 2020 Jun; 19(1):112. PubMed ID: 32600329
[TBL] [Abstract][Full Text] [Related]
8. Tumor-derived exosomal miR-148b-3p mediates M2 macrophage polarization via TSC2/mTORC1 to promote breast cancer migration and invasion.
Hao C; Sheng Z; Wang W; Feng R; Zheng Y; Xiao Q; Zhang B
Thorac Cancer; 2023 Jun; 14(16):1477-1491. PubMed ID: 37144254
[TBL] [Abstract][Full Text] [Related]
9. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis.
Shang A; Gu C; Wang W; Wang X; Sun J; Zeng B; Chen C; Chang W; Ping Y; Ji P; Wu J; Quan W; Yao Y; Zhou Y; Sun Z; Li D
Mol Cancer; 2020 Jul; 19(1):117. PubMed ID: 32713345
[TBL] [Abstract][Full Text] [Related]
10. Macrophages in immunoregulation and therapeutics.
Chen S; Saeed AFUH; Liu Q; Jiang Q; Xu H; Xiao GG; Rao L; Duo Y
Signal Transduct Target Ther; 2023 May; 8(1):207. PubMed ID: 37211559
[TBL] [Abstract][Full Text] [Related]
11. CHD4 promotes acquired chemoresistance and tumor progression by activating the MEK/ERK axis.
Wu J; Zhou Z; Li J; Liu H; Zhang H; Zhang J; Huang W; He Y; Zhu S; Huo M; Liu M; Zhang C
Drug Resist Updat; 2023 Jan; 66():100913. PubMed ID: 36603431
[TBL] [Abstract][Full Text] [Related]
12. Signaling pathways and therapeutic interventions in gastric cancer.
Lei ZN; Teng QX; Tian Q; Chen W; Xie Y; Wu K; Zeng Q; Zeng L; Pan Y; Chen ZS; He Y
Signal Transduct Target Ther; 2022 Oct; 7(1):358. PubMed ID: 36209270
[TBL] [Abstract][Full Text] [Related]
13. Tumor-derived exosomes in the cancer immune microenvironment and cancer immunotherapy.
Tang Q; Yang S; He G; Zheng H; Zhang S; Liu J; Wei S; Fan Q; Peng X; Li X; Zhang D; Yang L; Li H
Cancer Lett; 2022 Nov; 548():215823. PubMed ID: 35835409
[TBL] [Abstract][Full Text] [Related]
14. Circular RNAs: Characterization, cellular roles, and applications.
Liu CX; Chen LL
Cell; 2022 Jun; 185(12):2016-2034. PubMed ID: 35584701
[TBL] [Abstract][Full Text] [Related]
15. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Ajani JA; D'Amico TA; Bentrem DJ; Chao J; Cooke D; Corvera C; Das P; Enzinger PC; Enzler T; Fanta P; Farjah F; Gerdes H; Gibson MK; Hochwald S; Hofstetter WL; Ilson DH; Keswani RN; Kim S; Kleinberg LR; Klempner SJ; Lacy J; Ly QP; Matkowskyj KA; McNamara M; Mulcahy MF; Outlaw D; Park H; Perry KA; Pimiento J; Poultsides GA; Reznik S; Roses RE; Strong VE; Su S; Wang HL; Wiesner G; Willett CG; Yakoub D; Yoon H; McMillian N; Pluchino LA
J Natl Compr Canc Netw; 2022 Feb; 20(2):167-192. PubMed ID: 35130500
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
